Prostate Cancer Screening

PSA testing and prostate assessment for early cancer detection

Prostate cancer is the most common cancer in men — and when detected early, it is highly treatable. Our prostate screening programme combines PSA testing, clinical assessment and, where indicated, multiparametric MRI to identify concerns early and guide appropriate next steps.

Screening is offered from age 50 (or 45 for high-risk individuals including those of African descent or with a family history), with results interpreted in context by an experienced urologist.

Key Benefits

PSA blood test enables early detection of prostate changes
Urologist-led assessment puts results in clinical context
MRI and biopsy pathway for elevated or rising PSA
Balances detection with avoiding over-treatment

Is This Treatment Right For You?

Men aged 50+ wanting prostate cancer screening
Those aged 45+ with family history or African ancestry
Men with urinary symptoms or elevated PSA on routine testing

What to Expect

Urological Consultation

Risk factors, urinary symptoms and family history reviewed.

PSA Blood Test

PSA measured from a simple blood draw.

DRE

Digital rectal examination to assess prostate size and texture.

Results & Pathway

PSA result contextualised; MRI or biopsy arranged if indicated.

Recovery & Aftercare

No downtime for PSA and DRE screening.

Frequently Asked Questions

Does a raised PSA mean cancer?

No — PSA can be elevated by BPH, prostatitis or other benign conditions; a raised PSA is an indication for further investigation, not a cancer diagnosis.

How often should I have a PSA test?

Annually from age 50 (or 45 for high-risk men); more frequently if a previous result was borderline or rising.